Researchers at Cold Spring Harbor Laboratory have developed a potential therapeutic for diffuse intrinsic pontine glioma (DIPG) using antisense oligonucleotide technology. The treatment has slowed tumor growth, reversed changes in cancer cells, and increased survival rates in mice with DIPG.
Scientists have created a new method to model liver cancer tumor subtypes using CRISPR-Cas9, discovering that specific gene isoforms can lead to different cancer subtypes. This platform could help researchers develop new therapeutic interventions for treating cancer and other diseases.
Researchers have discovered that the amygdala uses specialized neurons to learn about threats and rewards, a finding that could lead to more effective treatments for anxiety and drug addiction. By studying how these neurons respond differently to various stimuli, scientists have gained insights into the brain's reward system.
A new shape-shifting antibiotic has been developed by Cold Spring Harbor Laboratory researchers, offering a potential cure for deadly infections caused by drug-resistant bacteria. The innovative design uses click chemistry to create a molecule with multiple possible configurations, avoiding the development of resistance.
Researchers have created a new tool, EN-TEx, to analyze genetic mutations and predict disease risk. The catalog of allele-specific variants provides rich data for accurate personal genomics, enabling scientists to study the effects of genetic mutations in tissues that are difficult to obtain without surgery.
Researchers at Cold Spring Harbor Laboratory have created a method to safely synthesize the cancer-fighting molecule JA, which has shown promise in treating triple-negative breast cancer. The team found that JA inhibits metabolic activity in cancer cells, starves them of energy and building blocks, leading to cell death.
Researchers have discovered a surprising mechanism by which the molecular machine Dis3L2 unwinds and destroys RNA molecules. By changing shape, Dis3L2 reveals an RNA-splitting wedge, allowing it to execute its tasks in a more dynamic and versatile way.
Scientists at Cold Spring Harbor Laboratory have found a way to reprogram cells causing Ewing sarcoma to behave like normal connective tissue cells. By blocking the protein ETV6, cancer cells can be forced to take on a new identity and grow less aggressively.
A new software developed by researchers at Cold Spring Harbor Laboratory can accurately infers continental ancestry from tumor DNA and RNA. This technology has the potential to lead to more targeted and personalized cancer treatments by identifying genetic connections between cancer and race or ethnicity.
A team of researchers from Cold Spring Harbor Laboratory has made a breakthrough in understanding the deadly brain cancer glioblastoma. By linking the BRD8 protein to another key protein, P53, they have identified a potential target for new treatments that could extend patient survival and improve outcomes.
Researchers found that dopamine-releasing neurons in the ventral tegmental area of the brain drive maternal instincts through reinforcement learning. This process creates an expectation of future rewards, influencing mothers to pick up their crying children again.
A new AI evaluation framework, GOPHER, has been developed to assess the efficiency of genome analysis algorithms. The tool judges programs on their ability to learn genomic biology, predict patterns, handle noise, and provide interpretable decisions.
The study provides detailed pictures of NMDA receptors, which mediate essential signals between neurons. The findings have significant implications for treating schizophrenia, depression, and other neuropsychiatric conditions.
Researchers at CSHL have created genetic blueprints for two types of groundcherry, which can guide plant geneticists in unlocking their potential. The new models also uncovered a gene essential for inflated calyx development, shedding light on the evolutionary process behind this unique trait.
A new computational model based on fruit fly brain data may help explain how humans process memories and experiences. The model suggests that living organisms, including humans, use a similar '1-2-3-many' count sketch to track encounters with familiar sights and smells.
Scientists have created an extensive new map of the brain's olfactory circuits, revealing a complex system that processes different aspects of odor information. The map suggests the existence of parallel neural circuits dedicated to assessing smell identity, pleasantness, and origin, offering new insights into olfactory processing.
A team of researchers has identified specific neurons in the amygdala that drive mice to eat fatty or sugary foods, even when not hungry. Switching off these neurons reduced overeating and protected against obesity, while also boosting physical activity and improving metabolic health.
Researchers at Cold Spring Harbor Laboratory discovered that tufted cells in the olfactory bulb are better at recognizing smells than mitral cells. This finding sheds light on how the brain processes sensory information, including smell intensity and identity.
Research reveals that oligodendrocyte precursor cells (OPCs) contribute to the pruning process, helping shape a healthy brain during early development. OPCs actively engulf synapses, eliminating connections that are no longer needed, and play an intermediary role between external experiences and brain activity.
Researchers have discovered a drug candidate that can prevent lethal lung inflammation in mice by inhibiting PTP1B, a protein that accelerates neutrophil aging and reduces tissue damage. The treatment shows promise for treating acute respiratory distress syndrome (ARDS) and other inflammatory conditions.
A new computer program, ExtRaINSIGHT, has been developed to track harmful mutations in the human genome throughout evolution. The study found three regions of the genome that are extremely sensitive to mutations, including splice sites, miRNA molecules, and central nervous system genes.
A study from Cold Spring Harbor Laboratory discovered a new list of friendly proteins generated by the human thymus that protects healthy tissue from T cell attacks. This finding may lead to improved treatments for autoimmune disorders such as multiple sclerosis and diabetes.
Researchers at Cold Spring Harbor Laboratory have developed a rapid organoid screening test that can predict response to neoadjuvant chemotherapy in pancreatic cancer patients. This test may help optimize personalized treatment plans and improve patient outcomes.
A new treatment approach using antisense oligonucleotides (ASOs) may help reduce cystic fibrosis symptoms and improve quality of life for patients with a specific gene mutation. The ASO strategy tricks cells into making an imperfect but functional version of the CFTR protein, which is better than having none at all.
Researchers have discovered pairing Spinraza with valproic acid (VPA) can boost its therapeutic effects without increasing toxicity. This approach allows for improved SMN protein production in SMA patients, leading to longer survival and better muscle function.
Researchers at Cold Spring Harbor Laboratory have discovered a protein interaction that may be an Achilles heel of tuft cell lung cancer. Disrupting this interaction could lead to more targeted therapies for the deadly disease, which originates from cells known as tuft cells.
Researchers at Cold Spring Harbor Laboratory have discovered a way to regulate plant growth by manipulating proteins called UBP12 and UBP13, which helps control the amount of CRY2 photoreceptor in plants. This finding has potential applications in improving crop yields and informing cancer research.
Researchers at Cold Spring Harbor Laboratory have made a breakthrough in understanding how the RNAi process keeps cells healthy. They discovered that the workhorse protein Argonaute (Ago) uses phosphorylation to break its grip on mRNA targets, allowing it to repress other proteins.
Researchers found that hormone fluctuations, particularly estrogen, shape brain development and behavior. Estrogen influences the growth of brain regions, leading to permanent changes in neural circuitry.
Researchers have created a biobank of breast cancer organoids from 87 patient tumor samples, including nearly half that are 'triple negative', an aggressive form of the disease. The biobank allows scientists to test specific drugs on those cancers in a dish, potentially leading to better treatment options.
Researchers found that gene duplications can complicate crop improvements, with some plants showing little effect despite similar mutations. This study highlights the need to understand evolutionary changes in plant genomes to develop more predictable crop improvements.
Researchers at Cold Spring Harbor Laboratory have discovered that the brain region responsible for social behavior, the locus coeruleus, is activated precisely when a mother retrieves her pup. This finding could help reveal causes of disorders such as depression, anxiety, and autism, leading to potential new treatments.
A recent study found that enzyme Dicer plays a crucial role in maintaining the structural integrity of chromosomes. In mammalian cells, Dicer works with protein BRD4 to promote genome stability. Removing Dicer from embryonic stem cells caused chromosome misalignment and cell death.
In a breakthrough discovery, microglia have been found to play a crucial role in forming critical synapses in the brain, particularly in chandelier cells. This finding suggests that immune cells may not only remove unwanted connections but also nurture their formation, which is essential for cognitive functioning.
Researchers found that ant colonies use an algorithm similar to the internet's data optimization, which senses and stabilizes behavior. This principle is also used in cells and neurons. Nature's algorithms may inspire new cybersecurity strategies or alternative approaches to gene regulation.
Researchers discovered that cancer cells use a combination of proteins to repel T cells and protect themselves from the immune system. By disabling this protection, scientists were able to allow T cells to infiltrate and attack pancreatic tumors, leading to shrinkage or disappearance.
Researchers studied microorganisms, including TB bacteria, to understand how genetic mutations drive adaptation and resistance. They found that certain types of mutations are more common than others, and this imbalance can help scientists predict which mutations will lead to drug resistance.
Researchers have discovered disulfiram prevents the formation of toxic webs known as neutrophil extracellular traps (NETs) that contribute to acute respiratory distress syndrome (ARDS). Disulfiram's ability to block NET formation may lead to a new treatment for severe COVID-19 and other lung injuries.
Scientists at Cold Spring Harbor Laboratory have developed a way to interfere with the energy pathway that allows liver cancer to grow and spread by targeting the pyruvate kinase protein. This approach uses antisense oligonucleotides, which reduce tumor development in mouse models, offering a potential treatment for liver cancer.
Scientists found smaller, faster waves in the visual cortex that relate to how attentive the brain is. These wave patterns may help understand sleep, anesthesia, and attention by suppressing irrelevant information. The discovery could also improve artificial brains using machine learning techniques.
Researchers at Cold Spring Harbor Laboratory develop a novel method to modify the CFTR gene, allowing for the production of functional protein in patients with certain mutations. The technique involves using antisense oligonucleotides to skip over the mutation and produce a partially functional protein.
Plant cells use RNA signals to coordinate growth, but these signals require a special escort protein to reach the right cells. Without this protein, plants fail to develop properly, highlights a crucial step in understanding how information is exchanged between cells.
Researchers at Cold Spring Harbor Laboratory discovered a previously unknown protein called SCP4 that plays a crucial role in the survival of acute myeloid leukemia cells. The study found that SCP4 can pair with specific kinases to regulate cell activity, and targeting this pathway may lead to effective treatment options.
Researchers at Cold Spring Harbor Laboratory identified a group of neurons in the mouse brain that regulates motivation and prevents addiction. Increasing activity of these neurons enhances task performance, but not to the point of addiction.
Researchers discovered that pregnancy triggers the activation of Natural Killer T (NKT) cells to prevent breast cancer. After pregnancy, breast epithelial cells produce a specific protein called CD1d, which attracts NKT cells to monitor and eliminate potential cancer cells.
Researchers have paired Barton's base, a 1980s catalyst, with click chemistry to accelerate complex molecule generation in biomedical research and drug development. The new ASCC method skips intermediate steps, reducing waste and enhancing 'green credentials',
Scientists have identified a cascade of four proteins that activate the cancer-causing protein ∆Np63α. By inhibiting these proteins, cancer stem cells can be controlled, and tumor growth slowed. This breakthrough offers new therapeutic options for squamous cell carcinoma.
Researchers have developed a new approach to studying prostate cancer, allowing them to track the behavior of individual cancer cells from birth to organ spread. The technique uses whole-organ imaging and artificial intelligence to create a 3D reconstruction of the organ at single-cell resolution.
Plants redirect resources from root growth to stem development when shaded, limiting yields and biomass. Researchers discovered key genes involved in this process, including WRKY proteins and ethylene signaling.
Researchers discovered that acute myeloid leukemia (AML) depends on a transporter to bring in inositol, a sugar required for cells to survive. By blocking this transporter, cancer cells would starve without inositol. This method leaves normal cells unharmed as they can produce their own inositol.